View drug registration information details.


ItemsRegistration information
ID213
No213
Brand NameTAZEDX
IngredientsTAZEMETOSTAT 200 MG
Dosage FormTABLET
Primary PackagingBOTTLE
StorageSTORE BELOW 30 C
Shelf Life2 YEARS
Pack SizeBOX OF 80'S/BOTTLE
Dispensing CategoryPRESCRIPTION
ATC Classification
Pharmaceutical ClassANTINEOPLASTIC
IndicationsFOR THE TREATMENT OF ADULTS AND PEDIATRIC PATIENTS AGED 16 YEARS AND OLDER WITH METASTATIC OR LOCALLY ADVANCED EPITHELIOID SARCOMA NOT ELIGIBLE FOR COMPLETE RESECTION
Contraindications
Side Effects
Unit Price
EDL No
DescriptionROUND, PINK FILM COATED TABLET, LETTER DX ON ONE SIDE AND 200 ON THE OTHER SIDE
Note
License OwnerBIGBEAR PHARMACEUTICAL LAO CO.,LTD
ManufacturerBIGBEAR PHARMACEUTICAL LAO CO.,LTD
CountryLAOS
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No07 L 1139/24
FDD Registration Date2024-07-12
Expiry Date2027-07-11

Back to drug list